CRA provided testimony in support of Masimo in its successful effort to refute monopolization, tying, and other antitrust counterclaims following a competitor’s infringement of its medical device patents. The team was led by Tim Snail and included Sharon Pang, Eyal Dvir, Omeed Alerasool, Ryne Belliston, Carl Hayden, Daniel Ladd, Joseph Marin, Flore Nouvel, and Sarah Black.
Merger Enforcement Guidelines Review: Comments on algorithms for merger review
CRA’s Dr. Alex Arsenault recently submitted comments to the Canadian Competition Bureau’s review of Merger Enforcement Guidelines (MEGs). Dr. Arsenault’s...